What is Brief History of Materialise Company?

What is the history of Materialise?

Materialise, a pioneer in 3D printing, was founded in June 1990 by Wilfried Vancraen and Hilde Ingelaere in Leuven, Belgium. From its inception, the company aimed to advance additive manufacturing beyond prototyping, focusing on innovative software and applications. This forward-thinking approach laid the groundwork for its future success.

Materialise's journey began with a vision to empower the entire additive manufacturing ecosystem through foundational software development. This strategic focus allowed the company to build a comprehensive suite of tools essential for designing, preparing, and managing complex 3D printing workflows.

The company's impact is deeply rooted in its dual offering of cutting-edge software and on-demand manufacturing services. This comprehensive approach supports industries ranging from healthcare to aerospace, enabling the creation of everything from prototypes to end-use parts. A notable aspect of their innovation can be seen in solutions like the Materialise BCG Matrix, which aids in strategic product portfolio analysis within the additive manufacturing space.

As of Q1 2025, Materialise reported total revenues of 66,379 kEUR. The Medical segment showed particularly strong performance with an 18.7% year-over-year increase, underscoring the company's significant contributions to patient-specific solutions in healthcare.

The Materialise company history began in June 1990 when Wilfried Vancraen and Hilde Ingelaere established the firm in Leuven, Belgium. Their venture into the burgeoning field of rapid prototyping started with a focus on providing 3D-printed parts as a service, making them the first service bureau of its kind in the Benelux region.

Materialise Company Origins

Founded in June 1990 by Wilfried Vancraen and Hilde Ingelaere, Materialise was established in Leuven, Belgium. The company's initial focus was on rapid prototyping services, utilizing a single Stereolithography machine.

• Wilfried Vancraen and Hilde Ingelaere are the founders.
• The company was founded in June 1990.
• Location of founding: Leuven, Belgium.
• Initial business: Rapid prototyping service bureau.

The founders, Wilfried Vancraen and Hilde Ingelaere, recognized the potential of 3D printing to accelerate design iterations. Wilfried Vancraen, who continues to lead the company as CEO, played a pivotal role in its innovative trajectory. A significant turning point occurred in 1992 when Vancraen observed the parallels between 3D printing files and medical scan data. This insight was crucial, leading to a strategic expansion into the medical sector and the development of key software products like Mimics for medical image processing and Magics for industrial applications.

The early days of Materialise involved limited seed capital, a common characteristic of university spin-offs. The company's strategy from the outset balanced additive manufacturing services with software development. This period coincided with the early adoption and growing recognition of 3D printing technology, with Materialise positioning itself as a key facilitator of this emerging industrial paradigm. The company's evolution showcases a strong commitment to innovation, as detailed in the Revenue Streams & Business Model of Materialise article.

Complete Materialise Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

The early growth of the Materialise company was characterized by groundbreaking product introductions and strategic market expansions. From its inception, the company focused on leveraging 3D printing technology for practical applications, quickly establishing itself as a leader in specialized software and services.

Pioneering Medical Software

In 1992, Materialise launched its Mimics software, revolutionizing medical image-based modeling for 3D printing. This early innovation cemented the company's strong presence in the medical sector, alongside the development of its industrial software, Magics, both commercialized to drive growth.

Advancements in 3D Printing Capabilities

By 1995, Materialise achieved a significant milestone by being the first to produce 3D printed parts in multiple colors, particularly for anatomical models to aid surgical planning. The subsequent year saw the development of the first customized 3D printed surgical guide for dental procedures, showcasing early personalized healthcare applications.

Expanding Service Offerings and Market Reach

Materialise introduced one of the first online 3D printing ordering systems, Materialise NextDay, in 1997, enabling rapid turnaround for custom parts. The company also developed large-scale stereolithography systems, the Mammoth series, capable of printing models over 2 meters in height.

Strategic Partnerships and Consumer Products

A collaboration with Phonak in 2000 led to Rapid Shell Modeling (RSM) software for custom hearing aids, a technology now integral to 99% of hearing aid production. The company also ventured into hardware with the Mammoth Stereolithography 3D printer and launched .MGX by Materialise in 2003, one of the first 3D printed consumer brands for end-use products.

Software Enhancements and Acquisitions

The introduction of 3-matic software in 2004 streamlined STL file editing for 3D printer users. Further expansion occurred in 2006 with the acquisition of OBL, specializing in custom cranio-maxillofacial implants, thereby broadening the company's medical applications.

Public Offering and Global Expansion

Materialise became a publicly traded company on June 25, 2014, listed on NASDAQ (MTLS), which facilitated further growth in services and software development. The same year, the acquisition of OrthoView and the establishment of Materialise Shanghai Co. Ltd. marked significant steps in global expansion and specialized software development.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The Materialise company history is marked by significant milestones and groundbreaking innovations in the 3D printing industry, alongside navigating various market challenges. From its origins, the company has consistently pushed the boundaries of what's possible with additive manufacturing, establishing itself as a key player in the field.

Materialise's innovations have profoundly impacted various sectors, particularly healthcare and manufacturing. The company's development of Mimics software in 1992 revolutionized surgical planning by converting 2D medical scans into 3D models, leading to more precise procedures and patient-specific implants. Their early adoption of multi-color printing in 1995 and the creation of the first customized 3D printed surgical guides for dentistry in 1996 further cemented their role as pioneers in personalized solutions.

Medical Image-Based Modeling

In 1992, Materialise launched Mimics software, a groundbreaking innovation that transformed 2D medical images into 3D models, significantly advancing surgical planning and the creation of patient-specific medical devices.

Multi-Color 3D Printing

Materialise achieved a significant milestone in 1995 by becoming the first company to produce multi-color 3D printed parts, enhancing the clarity and utility of anatomical models for surgical applications.

Online 3D Printing Ordering

The introduction of Materialise NextDay (now OnSite) in 1997 marked one of the earliest online ordering systems for 3D printing, making the technology more accessible to a wider range of users.

Advanced Software Development

The launch of 3-matic software in 2004 provided users with the ability to directly edit STL files, a critical advancement for optimizing designs for 3D printing, while e-Stage software in 2008 automated support structure generation.

Titanium Implants

In 2006, Materialise developed the first Titanium 3D printed skull implants, showcasing the company's capability in producing high-performance, biocompatible implants for complex medical cases.

Software Ecosystem Expansion

The acquisition of Link3D Inc. in 2021 significantly strengthened Materialise's software offerings, integrating new capabilities and expanding its reach within the additive manufacturing software market.

Despite its successes, Materialise has encountered challenges inherent to the rapidly evolving additive manufacturing sector. The industry has experienced fluctuations in investment and profitability for many public companies, and macroeconomic and geopolitical factors have impacted Materialise's Manufacturing and Software segments. For instance, Q2 2025 saw a 5.8% decrease in total consolidated revenue compared to Q2 2024, primarily due to softness in these areas.

Market Volatility

The additive manufacturing industry is subject to investment cycles and market shifts, which can affect revenue streams and growth trajectories for companies like Materialise.

Macroeconomic Headwinds

Broader economic and geopolitical conditions can create headwinds, leading to decreased demand and impacting the performance of specific business segments, as observed in Materialise's Q2 2025 results.

Segment Performance Fluctuations

While the Medical segment showed strong growth of 16.7% in Q2 2025, the Manufacturing and Software segments experienced softness, highlighting the need for strategic diversification and adaptation to market dynamics.

Operational Resilience

Despite revenue challenges, Materialise has demonstrated operational resilience, maintaining a positive net result and improving its gross profit margin to 58.3% in Q2 2025 through focused cost efficiencies.

Strategic Adaptation

The company's ability to adapt through strategic pivots, such as emphasizing personalized healthcare and leveraging its robust software ecosystem, has been crucial in overcoming obstacles and ensuring continued development.

Scalability and Efficiency

Recent strategic partnerships in 2025 with companies like Raplas and One Click Metal aim to accelerate efficiencies and scalability in additive manufacturing, addressing the ongoing need for operational improvement.

Materialise Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

The Materialise company history is a testament to continuous innovation in additive manufacturing, beginning with its founding in June 1990 in Leuven, Belgium. From its origins as a rapid prototyping service bureau, the company has consistently pushed the boundaries of 3D printing technology and its applications, particularly in the medical field. This evolution showcases a deep commitment to leveraging 3D printing for tangible improvements in various industries.

Continued Medical Innovation

The company's commitment to the medical sector is evident in its ongoing development of patient-specific solutions. The upcoming availability of personalized knee guides in the U.S. market highlights this focus.

Software Advancements

The unveiling of Magics 2025 signifies continuous improvement in their software offerings. Strategic partnerships further enhance their technological capabilities and market reach.

Financial Performance and Outlook

For the full fiscal year 2025, the company initially projected consolidated revenue between 270,000 to 285,000 kEUR. Despite revised expectations of €265 million to €280 million due to market uncertainties, the adjusted EBIT target remains. This demonstrates resilience and a strategic approach to navigating economic conditions.

Long-Term Strategy: Mass Personalization

The company's long-term strategy, termed 'mass personalization', aims to expand its reach to more patients with tailored solutions. This vision aligns with driving industrial adoption of 3D printing by delivering clear business value and fostering collaboration, building upon its Growth Strategy of Materialise.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE